ROLE OF SRC AND FAK IN STORE-OPERATED CA 2+ ENTRY
SRC 和 FAK 在商店经营的 CA 2 条目中的作用
基本信息
- 批准号:6625106
- 负责人:
- 金额:$ 31.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-05-01 至 2005-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In nonexcitable cells, the depletion of internal Ca2+ stores leads
to the activation of store-operated channels (SOCs) which play an important
role in physiological processes such as refilling of Ca2+ stores, regulation of
secretion, regulation of gene transcription, control of cell cycle and
proliferation, and regulation of apoptosis. Until recently, what little was
known about the signaling mechanism for coupling depletion of Ca2+ stores to
activation of SOCs was based on a number of pharmacological studies which
implicated a variety of potential regulatory pathways. For example, based on
studies with a series of tyrosine kinase and tyrosine phosphatase inhibitors, a
role for tyrosine kinases in the regulation of SOCs was proposed. During the
previous grant period, a molecular approach provided evidence for the
involvement of c-src and focal adhesion kinase (FAK) in the regulation of SOCs.
To our knowledge, this makes the tyrosine kinase pathway the first to have both
pharmacological and molecular data supporting its involvement in the signaling
mechanism for activation of SOCs. In this proposal, experiments are described
to elucidate the events downstream of c-src and FAK in the activation of SOCs.
This will extend the studies which demonstrate that store-operated Ca2+ entry
(SOCE) is dramatically reduced in fibroblasts from transgenic src_ mice, but
can be restored by transfecting wild type c-src into these cells. Experiments
are proposed specifically to 1) express a series of src mutants to determine
which domains of c-src are necessary to activate SOCE. In addition, mutants of
FAK, Grb2 and Shc, which are known to interfere with signaling downstream from
the src/FAK complex in the integrin signaling pathway, will be expressed to
determine whether they block activation of SOCE. The primary hypothesis is that
the tyrosine kinase activity of c-src is both necessary and sufficient to
activate SOCE. 2) Determine which proteins are involved in SOCE in HEK-293
cells as a means of identifying potential targets of tyrosine kinase activity
of c-src and FAK. While there is strong evidence that trp is a SOC in
Drosophila, there is still uncertainty concerning which of the 7 mammalian trp
homologs identified to date are SOCs. In the last grant period 4 trp homologs
were identified as being expressed in HEK-293 cells and antisense constructs
specific for each were made. The expression of individual trp homologs will be
blocked and the effect on SOCE assessed by fura-2 and electrophysiological
approaches. 3) Determine whether the protein responsible for SOCE in HEK-293
cells is directly tyrosine phosphorylated when SOCE is activated. If this
proves negative, he will investigate the tyrosine phosphorylation of accessory
proteins which directly interact with trp proteins (e.g. calmodulin and the
human homolog of InaD, a regulatory protein for Drosophilia trp). The
successful outcome of these experiments would create a significant breakthrough
in our understanding of how SOCs are regulated.
在非兴奋性细胞中,内部Ca 2+储存的耗尽导致
激活商店运营的渠道(SOC),
在生理过程中的作用,如Ca 2+储存的再填充,
分泌、基因转录调节、细胞周期控制和
增殖和细胞凋亡的调节。直到最近,
已知将Ca 2+储存耗尽与
SOC的激活基于大量药理学研究,
暗示了多种潜在的调节途径。例如基于
一系列酪氨酸激酶和酪氨酸磷酸酶抑制剂的研究,
提出了酪氨酸激酶在SOC调节中的作用。期间
在上一个赠款期间,分子方法为
c-src和粘着斑激酶(FAK)参与SOC的调节。
据我们所知,这使得酪氨酸激酶途径成为第一个具有这两种功能的途径。
药理学和分子数据支持其参与信号传导
激活SOC的机制。在这个建议中,实验描述
阐明c-src和FAK在SOC活化中的下游事件。
这将扩展研究,证明钙池操作的Ca 2+进入
(SOCE)在转基因src_小鼠的成纤维细胞中显著降低,但
可以通过将野生型c-src转染到这些细胞中来恢复。实验
具体建议1)表达一系列src突变体,以确定
c-src的哪些结构域是激活SOCE所必需的。此外,
FAK、Grb 2和Shc,已知它们干扰来自
整合素信号通路中的src/FAK复合物将表达,
确定它们是否阻止SOCE的激活。主要假设是,
c-src的酪氨酸激酶活性是必需的
启动SOCE。2)确定哪些蛋白质参与HEK-293中的SOCE
细胞作为鉴定酪氨酸激酶活性的潜在靶点的手段
c-src和FAK。虽然有强有力的证据表明trp是一种SOC,
在果蝇中,7种哺乳动物中哪一种trp仍不确定。
迄今为止鉴定的同源物是SOC。在上一个资助期,
被鉴定为在HEK-293细胞和反义构建体中表达
对每一种都有具体规定。单个trp同源物的表达将是
阻断,并通过fura-2和电生理学评估对SOCE的影响
接近。3)确定HEK-293中负责SOCE的蛋白质是否
当SOCE被激活时,细胞直接酪氨酸磷酸化。如果这
如果证明是阴性的,他将研究辅助细胞的酪氨酸磷酸化,
与Trp蛋白直接相互作用的蛋白质(例如钙调蛋白和
InaD的人类同源物,果蝇trp的调节蛋白)。的
这些实验的成功结果将创造一个重大突破
我们对SOC监管方式的理解。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gene expression profiles in HEK-293 cells with low or high store-operated calcium entry: can regulatory as well as regulated genes be identified?
具有低或高钙库操纵钙进入的 HEK-293 细胞中的基因表达谱:是否可以鉴定调节基因和被调节基因?
- DOI:10.1152/physiolgenomics.00099.2004
- 发表时间:2005
- 期刊:
- 影响因子:4.6
- 作者:Zagranichnaya,TatianaK;Wu,Xiaoyan;Danos,ArpadM;Villereal,MitchelL
- 通讯作者:Villereal,MitchelL
Mechanism and functional significance of TRPC channel multimerization.
- DOI:10.1016/j.semcdb.2006.10.010
- 发表时间:2006-12
- 期刊:
- 影响因子:7.3
- 作者:M. Villereal
- 通讯作者:M. Villereal
Differential tyrosine phosphorylation of plasma membrane Ca2+-ATPase and regulation of calcium pump activity by carbachol and bradykinin.
质膜 Ca2-ATP 酶的差异酪氨酸磷酸化以及卡巴胆碱和缓激肽对钙泵活性的调节。
- DOI:10.1074/jbc.m210418200
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Babnigg,György;Zagranichnaya,Tatiana;Wu,Xiaoyan;Villereal,MitchelL
- 通讯作者:Villereal,MitchelL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MITCHEL L VILLEREAL其他文献
MITCHEL L VILLEREAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MITCHEL L VILLEREAL', 18)}}的其他基金
ROLE OF SRC AND FAK IN STORE-OPERATED CA 2+ ENTRY
SRC 和 FAK 在商店经营的 CA 2 条目中的作用
- 批准号:
6476560 - 财政年份:1996
- 资助金额:
$ 31.39万 - 项目类别:
ROLE OF SRC AND FAK IN STORE-OPERATED CA 2+ ENTRY
SRC 和 FAK 在商店经营的 CA 2 条目中的作用
- 批准号:
6046301 - 财政年份:1996
- 资助金额:
$ 31.39万 - 项目类别:
ROLE OF SRC AND FAK IN STORE-OPERATED CA 2+ ENTRY
SRC 和 FAK 在商店经营的 CA 2 条目中的作用
- 批准号:
6329767 - 财政年份:1996
- 资助金额:
$ 31.39万 - 项目类别:
ROLE OF SRC AND FAK IN STORE-OPERATED CA 2+ ENTRY
SRC 和 FAK 在商店经营的 CA 2 条目中的作用
- 批准号:
6419274 - 财政年份:1996
- 资助金额:
$ 31.39万 - 项目类别:
相似海外基金
L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
- 批准号:
10668210 - 财政年份:2023
- 资助金额:
$ 31.39万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
- 批准号:
10603554 - 财政年份:2023
- 资助金额:
$ 31.39万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
- 批准号:
10684558 - 财政年份:2023
- 资助金额:
$ 31.39万 - 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
- 批准号:
10628914 - 财政年份:2023
- 资助金额:
$ 31.39万 - 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
- 批准号:
10815882 - 财政年份:2023
- 资助金额:
$ 31.39万 - 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
- 批准号:
10734121 - 财政年份:2023
- 资助金额:
$ 31.39万 - 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
- 批准号:
10628911 - 财政年份:2023
- 资助金额:
$ 31.39万 - 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
- 批准号:
2200474 - 财政年份:2022
- 资助金额:
$ 31.39万 - 项目类别:
Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
- 批准号:
452107 - 财政年份:2021
- 资助金额:
$ 31.39万 - 项目类别:
Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
- 批准号:
10399417 - 财政年份:2021
- 资助金额:
$ 31.39万 - 项目类别:














{{item.name}}会员




